The article by Kanthan and Shuaibl is a timely reminder of the potential importance of clinical applications of intracerebral microdialysis. However, there are several methodological and interpretive shortcomings in their case report. Firstly, the microdialysis probe used (Camegie CMA-10) is one which is designed solely for experimental use in animals. It has no human product licence. Conventional techniques for sterilisation of products to be used in humans can damage the components of the probe, alter its microdialysis characteristics, and may even result in the release of toxic substances. There are also examples of the dialysis membrane becoming detached from the probe shaft and being left in situ (R Bullock, personal communication, 1995 We thank Mr Whittle for his comments.
As regards the microdialysis probe CMA-10; we are aware that this product has not been marketed for human use. However, for research purposes these are being used in accordance with strict protocol regimes as followed in Professor Ungerstedt's laboratory. In our laboratory, extensive bench work has been carried out regarding presterilisation and post-sterilisation effects on the efficacy of the probe, concentrations of neurotransmitters, and on decay. The exact placement of the probe in the cortex of the frontal lobe was also done both in fresh necropsy and cadaveric brains before clinical use. These and other issues regarding the methodology have been published in our methods paper (J Neurosci Methods 1995; 60: 151-6).
The issue regarding the exact interpretation of the high concentrations of neurotransmitters remains speculative. We agree with Mr Whittle that it is conjectural whether these are the result or the cause of neuronal death. We also agree that the exact role of excitotoxic neurotransmitters to "secondary brain injury" remains unclear. It is precisely with this in mind that other extraneous factors were not explored in our case. However for the record, our patient was not hypoxic, hypotensive, or febrile during the in vivo microdialysis. Nevertheless, earlier such insults may be contributing factors to the high concentrations noted. This remains a complex issue and we advocate intracerebral in vivo microdialysis as an additional monitoring tool in understanding and unravelling these and other related phenomena of the exact pathogenesis of head trauma. At least in American jurisprudence, the presumption, traditionally, has been that the patient in a persistent vegetative state would wish to be kept alive; and, in tum, the burden has fallen on those desiring to terminate the treatment of the patient in a persistent
